Stage IIID Melanoma
Oncology
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Stage IIID Melanoma?
There are 1 clinical trial targeting Stage IIID Melanoma tracked by BioSniper.
What is the prevalence of Stage IIID Melanoma?
The estimated prevalence of Stage IIID Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Stage IIID Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis